• Paolo Tortori-Donati
  • Andrea Rossi
  • Roberta Biancheri
  • Cosma F. Andreula


The phakomatoses, also called neurocutaneous syndromes, are a heterogeneous group of congenital disorders primarily involving structures derived from the embryological neuroectoderm. Only the most common entities (i.e., neurofibromatosis types 1 and 2, tuberous sclerosis, Sturge-Weber syndrome, and von Hippel-Lindau syndrome) will be discussed in this chapter. The rare phakomatoses are described in Chapter 17.


Celiac Disease Tuberous Sclerosis Tuberous Sclerosis Complex Neurofibromatosis Type Focal Cortical Dysplasia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    National Institutes of Health Consensus Development Conference. Neurofibromatosis: Conference Statement. Arch Neurol 1988; 45:575–578.Google Scholar
  2. 2.
    Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, Rubenstein A, Viskochil D. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 1997; 278:51–57.PubMedGoogle Scholar
  3. 3.
    DeBella K, Poskitt K, Szudek J, Friedman JM. Use of „unidentified bright objects“ on MRI for diagnosis of neurofibromatosis 1 in children. Neurology 2000; 54:1646–1651.PubMedGoogle Scholar
  4. 4.
    Inoue Y, Nemoto Y, Tashiro T, Nakayama K, Nakayama T, Daikokuya H. Neurofibromatosis type 1 and type 2: review of the central nervous system and related structures. Brain Dev 1997; 19:1–12.PubMedGoogle Scholar
  5. 5.
    Herron J, Darrah R, Quaghebeur G. Intra-cranial manifestations of the neurocutaneous syndromes. Clin Radiol 2000; 55:82–98.PubMedGoogle Scholar
  6. 6.
    Shen MH, Harper PS, Upadhyaya M. Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet 1996; 33:2–17.PubMedGoogle Scholar
  7. 7.
    Vogel KS, Brannan C I, Jenkins NA, Copeland NG, Parada LF. Loss of neurofibromin results in neurotrophin-independent survival of embryonic sensory and sympathetic neurons. Cell 1995; 82:733–742.PubMedGoogle Scholar
  8. 8.
    Aicardi J. Diseases of the nervous system in childhood. 2nd edn. London: Mac Keith Press, 1998.Google Scholar
  9. 9.
    Linder B, Campos M, Shafer M. CT and MRI of orbital abnormalities in neurofibromatosis and selected craniofacial anomalies. Radiol Clin North Am 1987; 25:787–802.PubMedGoogle Scholar
  10. 10.
    Cutting LE, Koth CW, Burnette CP, Abrams MT, Kaufmann WE, Denckla MB. Relationship of cognitive functioning, whole brain volumes, and T2-weighted hyperintensities in neurofibromatosis-1. J Child Neurol 2000; 15:157–160.PubMedGoogle Scholar
  11. 11.
    Dubovsky EC, Booth TN, Vezina G, Samango-Sprouse CA, Palmer KM, Brasseux CO. MR imaging of the corpus callosum in pediatric patients with neurofibromatosis type 1. AJNR Am J Neuroradiol 2001; 22:190–195.PubMedGoogle Scholar
  12. 12.
    Steen RG, Taylor JS, Langston JW, Glass JO, Brewer VR, Reddick WE, Mages R, Pivnick E. Prospective evaluation of the brain in asymptomatic children with neurofibromatosis type 1: relationship of macrocephaly to T1 relaxation changes and structural brain abnormalities. AJNR Am J Neuroradiol 2001; 22:810–817.PubMedGoogle Scholar
  13. 13.
    Molloy PT, Bilaniuk LT, Vaughan SN, Needle MN, Liu GT, Zackai EH, Phillips PC. Brainstem tumors in patients with neurofibromatosis type 1: a distinct clinical entity. Neurology 1995; 45:1897–1902.PubMedGoogle Scholar
  14. 14.
    DiPaolo DP, Zimmerman RA. The phakomatoses. In: Zimmerman RA, Gibby WA, Carmody RF (eds) Neuroimaging. Clinical and Physical Principles. New York: Springer-Verlag, 2000:657–698.Google Scholar
  15. 15.
    Aoki S, Barkovich AJ, Nishimura K, Kjos BO, Machida T, Cogen P, Edwards M, Norman D. Neurofibromatosis types 1 and 2: cranial MR findings. Radiology 1989; 172:527–534.PubMedGoogle Scholar
  16. 16.
    Menor F, Marti-Bonmati L, Arana E, Poyatos C, Cortina H. Neurofibromatosis type 1 in children: MR imaging and follow-up studies of central nervous system findings. Eur J Radiol 1998; 26:121–131.PubMedGoogle Scholar
  17. 17.
    Barkovich AJ. Pediatric Neuroimaging, 3nd edn. Philadelphia: Lippincott Williams & Wilkins, 2000.Google Scholar
  18. 18.
    DiMario FJ Jr, Ramsby G. Magnetic resonance imaging lesion analysis in neurofibromatosis type 1. Arch Neurol 1998; 55:500–505.PubMedGoogle Scholar
  19. 19.
    Duffner PK, Cohen ME, Seidel FG, Shucard DW. The significance of MRI abnormalities in children with neurofibromatosis. Neurology 1989; 39:373–378.PubMedGoogle Scholar
  20. 20.
    Curless RG, Siatkowski M, Glaser JS, Shatz NJ. MRI diagnosis of NF-1 in children without cafe-au-lait skin lesions. Pediatr Neurol 1998; 18:269–271.PubMedGoogle Scholar
  21. 21.
    Braffman BH, Bilaniuk LT, Zimmerman RA. The central nervous system manifestations of the phakomatosis on MR. Radiol Clin North Am 1988; 26:773–800.PubMedGoogle Scholar
  22. 22.
    Smirniotopoulos JG, Murphy FM. The phakomatoses. AJNR Am J Neuroradiol 1992; 13:725–746.PubMedGoogle Scholar
  23. 23.
    Raininko R, Thelin L, Eeg-Olofson O. Atypical focal nonneoplastic brain changes in neurofibromatosis type 1: mass effect and contrast enhancement. Neuroradiology 2001; 43:586–590.PubMedGoogle Scholar
  24. 24.
    DiPaolo DP, Zimmerman RA, Rorke LB, Zackai EH, Bilaniuk LT, Yachnis AT. Neurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain. Radiology 1995; 195:721–724.PubMedGoogle Scholar
  25. 25.
    Sevick RJ, Barkovich AJ, Edwards MS, Koch T, Berg B, Lempert T. Evolution of white matter lesions in neurofibromatosis type 1: MR findings. AJR Am J Roentgenol 1992; 159:171–175.PubMedGoogle Scholar
  26. 26.
    Itoh T, Magnaldi S, White RM, Denckla MB, Hofman K, Naidu S, Bryan RN. Neurofibromatosis type 1: the evolution of deep gray and white matter MR abnormalities. AJNR Am J Neuroradiol 1994; 15:1513–1519.PubMedGoogle Scholar
  27. 27.
    Terada H, Barkovich AJ, Edwards MS, Ciricillo SM. Evolution of high-intensity basal ganglia lesions on T1-weighted MR in neurofibromatosis type 1. AJNR Am J Neuroradiol 1996; 17:755–760.PubMedGoogle Scholar
  28. 28.
    Griffiths PD, Blaser S, Mukonoweshuro W, Armstrong D, Milo-Mason G, Cheung S. Neurofibromatosis bright objects in children with neurofibromatosis type 1: a proliferative potential? Pediatrics 1999;104:e49.PubMedGoogle Scholar
  29. 29.
    Mukonoweshuro W, Griffiths PD, Blaser S. Neurofibromatosis type 1: the role of neuroradiology. Neuropediatrics 1999; 30:111–119.PubMedGoogle Scholar
  30. 30.
    Mirowitz SA, Sartor K, Gado M. High-intensity basal ganglia lesions on T1-weighted MR images in neurofibromatosis. AJNR Am J Neuroradiol 1989; 10:1159–1163.PubMedGoogle Scholar
  31. 31.
    Kim G, Mehta M, Kucharzyk W, Blaser S. Spontaneous regression of a tectal mass in neurofibromatosis. AJNR Am J Neuroradiol 1998; 19:1137–1139.PubMedGoogle Scholar
  32. 32.
    Raininko R, Thelin L, Eeg-Olofsson O. Non-neoplastic brain abnormalities on MRI in children and adolescent with neurofibromatosis type 1. Neuropediatrics 2001; 32:225–230.PubMedGoogle Scholar
  33. 33.
    Braffman BH, Bilaniuk LT, Zimmerman RA. MR of central nervous system neoplasia of the phakomatoses. Semin Roentgenol 1990; 25:198–217.PubMedGoogle Scholar
  34. 34.
    Legius E, Descheemaeker MJ, Spaepen A, Casaer P, Fryns JP. Neuropsychological profile in children with NF1. Genet Counsel 1994; 5:213–214.Google Scholar
  35. 35.
    Hofman KJ, Harris EL, Bryan RN, Denckla MB. Neurofibromatosis type 1: the cognitive phenotype. J Pediat 1994; 124:S1–S8.PubMedGoogle Scholar
  36. 36.
    North K, Joy P, Yuille D, Cocks N, Mobbs E, Hutchins P, McHugh K, de Silva M. Specific learning disability in children with neurofibromatosis type 1: significance of MRI abnormalities. Neurology 1994; 44:878–883.PubMedGoogle Scholar
  37. 37.
    North KN, Riccardi V, Samango-Sprouse C, Ferner R, Moore B, Legius E, Ratner N, Denckla MB. Cognitive function and academic performance in neurofibromatosis 1: consensus statement from the NF1 Cognitive Disorders Task Force. Neurology 1997; 48:1121–1127.PubMedGoogle Scholar
  38. 38.
    Ferner RE, Chaudhuri R, Bingham J, Cox T, Hughes RA. MRI in neurofibromatosis 1. The nature and evolution of increased intensity T2 weighted lesions and their relationship to intellectual impairment. J Neurol Neurosurg Psychiatry 1993; 56:492–495.PubMedGoogle Scholar
  39. 39.
    Legius E, Descheemaeker MJ, Steyaert J, Spaepen A, Vlietinck R, Casaer P, Demaerel P, Fryns JP. Neurofibromatosis type 1 in childhood: correlation of MRI findings with intelligence. J Neurol Neurosurg Psychiatry 1995; 59:638–640.PubMedGoogle Scholar
  40. 40.
    Moore BD, Slopis JM, Schomer D, Jackson EF, Levy BM. Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis. Neurology 1996; 46:1660–1668.PubMedGoogle Scholar
  41. 41.
    Eliason MJ. Neurofibromatosis: implications for learning and behavior. J Dev Behav Pediatr 1986; 7:175–179.PubMedGoogle Scholar
  42. 42.
    Stine S, Adams W. Learning problems in neurofibromatosis patients. Clin Orthop 1989; 245:43–48.PubMedGoogle Scholar
  43. 43.
    Hynd GW, Semrud-Clikeman M, Lorys AR, Novey ES, Eliopulos D, Lyytinen H. Corpus callosum morphology in attention deficit-hyperactivity disorder: morphometric analysis of MRI. J Learn Disabil 1991; 24:141–146.PubMedGoogle Scholar
  44. 44.
    Semrud-Clikeman M, Filipek PA, Biederman J, Steingard R, Kennedy D, Renshaw P, Bekken K. Attention-deficit hyperactivity disorder: magnetic resonance imaging morphometric analysis of the corpus callosum. J Am Acad Child Adolesc Psychiatry 1994; 33:875–881.PubMedGoogle Scholar
  45. 45.
    Giedd JN, Castellanos FX, Casey BJ, Kozuch P, King AC, Hamburger SD, Rapoport JL. Quantitative morphology of the corpus callosum in attention deficit hyperactivity disorder. Am J Psychiatry 1994; 151:665–669.PubMedGoogle Scholar
  46. 46.
    Kayl AE, Moore BD 3rd, Slopis JM, Jackson EF, Leeds NE. Quantitative morphology of the corpus callosum in children with neurofibromatosis and attention-deficit hyperactivity disorder. J Child Neurol 2000; 15:90–96.PubMedGoogle Scholar
  47. 47.
    Ilgren EB, Kinnier-Wilson LM, Stiller CA. Gliomas in neurofibormatosis: a series of 89 cases with evidence for ehnancement malignancy in associated cerebellar astrocytoma. Pathol Annu 1985; 20:331–358.PubMedGoogle Scholar
  48. 48.
    Menor F, Marti-Bonmati L, Mulas F, Cortina H, Olague R. Imaging considerations of central nervous system manifestations in pediatric patients with neurofibromatosis type 1. Pediatr Radiol 1991; 21:389–394.PubMedGoogle Scholar
  49. 49.
    Bognanno JR, Edwards MK, Lee TA, Dunn DW, Roos KL, Klatte EC. Cranial MR imaging in neurofibromatosis. AJNR Am J Neuroradiol 1988; 9:461–468.Google Scholar
  50. 50.
    Kornreich L, Blaser S, Schwarz M, Shuper A, Vishne TH, Cohen IJ, Faingold R, Michovitz S, Koplewitz B, Horev G. Optic pathway glioma: correlation of imaging findings with the presence of neurofibromatosis. AJNR Am J Neuroradiol 2001; 22:1963–1969.PubMedGoogle Scholar
  51. 51.
    Parazzini C, Triulzi F, Bianchini E, Agnetti V, Conti M, Zanolini C, Maninetti MM, Rossi LN, Scotti G. Spontaneous involution of optic pathway lesions in neurofibromatosis type 1: serial contrast MR evaluation. AJNR Am J Neuroradiol 1995; 16:1711–1718.PubMedGoogle Scholar
  52. 52.
    Listernick R, Louis DN, Packer RJ, Gutmann DH. Optic pathway gliomas in children with Neurofibromatosis 1: Consensus statement from the NF1 Optic pathway glioma Task Force. Neurology 1997; 41:143–149.Google Scholar
  53. 53.
    Smirniotopoulos JG, Murphy FM. Central nervous system manifestations of the phakomatoses and other inherited syndromes. In: Atlas SW (ed) MRI of the brain and spine. New York: Raven Press, 1991:773–802.Google Scholar
  54. 54.
    Spencer WH. Ophthalmic pathology. An Atlas and Textbook. Philadelphia: WB Saunders, 1985.Google Scholar
  55. 55.
    Stem J, Jakobiec FA, Housepien EM. The architecture of optic nerve gliomas with and without neurofibromatosis. Arch Ophtalmol 1980; 98:505–511.Google Scholar
  56. 56.
    Dowd CP, Atlas SW, Hoyt WF. Chiasm gliomas in neurofibromatosis patients: MR characteristics. Anual Meeting of the ASNR. Boston: 1988.Google Scholar
  57. 57.
    Tortori-Donati P, Fondelli MP, Rossi A, Cama A, Taccone A. Neurofibromatosi tipo 1. In: Tortori-Donati P, Taccone A, Longo M (eds) Malformazioni cranio-encefaliche. Neuroradiologia. Torino: Minerva Medica, 1996:345–363.Google Scholar
  58. 58.
    Perilongo G, Moras P, Carollo C, Battistella A, Clementi M, Laverda A, Murgia A. Spontaneous partial regression of low-grade glioma in children with neurofibromatosis-1: a real possibility. J Child Neurol 1999; 14:352–356.PubMedGoogle Scholar
  59. 59.
    Brzowski AE, Bazan C, Mumma JV, Ryan SG. Spontaneous regression of optic glioma in a patient with neurofibromatosis. Neurology 1992; 42:679–681.PubMedGoogle Scholar
  60. 60.
    Leisti EL, Pyhtinen J, Poyhonen M. Spontaneous decrease of a pilocytic astrocytoma in neurofibromatosis type 1. AJNR Am J Neuroradiol 1996; 17:1691–1694.PubMedGoogle Scholar
  61. 61.
    Shuper A, Horev G, Kornreich L, Michowiz S, Weitz R, Zaizov R, Cohen IJ. Visual pathway glioma: an erratic tumour with therapeutic dilemmas. Arch Dis Child 1997; 76:259–263.PubMedGoogle Scholar
  62. 62.
    Schmandt SM, Packer RJ, Vezina LG, Jane J. Spontaneous regression of low-grade astrocytomas in childhood. Pediatr Neurosurg 2000; 32:132–136.PubMedGoogle Scholar
  63. 63.
    Allen JC. Initial management of children with hypothalamic and thalamic tumors and the modifying role of neurofibromatosis-1. Pediatr Neurosurg 2000; 32:154–162.PubMedGoogle Scholar
  64. 64.
    Gallucci M, Catalucci A, Scheithauer BW, Forbes GS. Spontaneous involution of pilocytic astrocytoma in a patient without neurofibromatosis type 1: case report. Radiology 2000; 214:223–226.PubMedGoogle Scholar
  65. 65.
    Andreula CF, Recchia Luciani ANM. Le cosiddette facomatosi. Rivista di Neuroradiologia 1994; 7:231–240.Google Scholar
  66. 66.
    Huson SM, Hughes RAC (eds.) The Neurofibromatoses. A pathogenetic and clinical overview. London: Chapman and Hall, 1994:160–232.Google Scholar
  67. 67.
    Bilaniuk LT, Molloy PT, Zimmerman RA, Phillips PC, Vaughan SN, Liu GT, Sutton LN, Needle M. Neurofibromatosis type 1: brain stem tumours. Neuroradiology 1997; 39:642–653.PubMedGoogle Scholar
  68. 68.
    Pollack IF, Shultz B, Mulvihill JJ. The management of brainstem gliomas in patients with neurofibromatosis 1. Neurology 1996; 46:1652–1660.PubMedGoogle Scholar
  69. 69.
    Nofray JF, Darling C, Byrd S, Ross BD, Schwalm C, Miller R, Tomita T. Short TE proton MRS and neurofibromatosis type 1 intracranial lesions. J Comput Assist Tomogr 1999; 23:994–1003.Google Scholar
  70. 70.
    Castillo M, Green C, Kwock L, Smith K, Wilson D, Schiro S, Greenwood R. Proton MR spectroscopy in patients with neurofibromatosis type 1: evaluation of hamartomas and clinical correlation. AJNR Am J Neuroradiol 1995; 16:141–147.PubMedGoogle Scholar
  71. 71.
    Gonen O, Wang ZJ, Viswanathan AK, Molloy PT, Zimmerman RA. Three-dimensional multivoxel proton MR spectroscopy of the brain in children with neurofibromatosis type 1. AJNR Am J Neuroradiol 1999; 20:1333–1341.PubMedGoogle Scholar
  72. 72.
    Wang PY, Kaufmann WE, Koth CW, Denckla MB, Barker PB. Thalamic involvement in neurofibromatosis type 1: evaluation with proton magnetic resonance spectroscopic imaging. Ann Neurol 2000; 47:477–484.PubMedGoogle Scholar
  73. 73.
    Broniscer A, Gajjar A, Bhargava R, Langston JW, Heideman R, Jones D, Kun LE, Taylor J. Brain stem involvement in children with neurofibromatosis type 1: role of magnetic resonance imaging and spectroscopy in the distinction from diffuse pontine glioma. Neurosurgery 1997; 40:331–337.PubMedGoogle Scholar
  74. 74.
    Jones AP, Gunawardena WJ, Coutinho CMA. 1H MR spectroscopy evidence for the varied nature of asymptomatic focal brain lesions in neurofibromatosis type 1. Neuroradiology 2001; 43:62–67.PubMedGoogle Scholar
  75. 75.
    Eastwood JD, Fiorella DJ, MacFall JF, Delong DM, Provenzale JM, Greenwood RS. Increased brain apparent diffusion coefficient in children with neurofibromatosis type 1. Radiology 2001; 219:354–358.PubMedGoogle Scholar
  76. 76.
    Mori H, Abe O, Okubo T, Hayashi N, Yoshikawa T, Kunimatsu A, Yamada H, Aoki S, Ohtomo K. Diffusion property in a hamartomatous lesion of neurofibromatosis type 1. J Comput Assist Tomogr 2001; 25:537–539.PubMedGoogle Scholar
  77. 77.
    Riccardi VM. Von Recklinghausen neurofibromatosis. N Engl J Med 1981;305:1617–1627.PubMedGoogle Scholar
  78. 78.
    Russell DS, Rubinstein LJ. Pathology of tumors of the nervous system, 5th edn. Baltimore: Williams & Wilkins, 1989.Google Scholar
  79. 79.
    Thakkar SD, Feigen U, Mautner VF. Spinal tumours in neurofibromatosis type 1: an MRI study of frequency, multiplicity and variety. Neuroradiology 1999; 41:625–629.PubMedGoogle Scholar
  80. 80.
    Katz BH, Quencer RM. Hamartomatous spinal cord lesion in neurofibromatosis. AJNR Am J Neuroradiol 1989; 10(Suppl. 5):S101.PubMedGoogle Scholar
  81. 81.
    Egelhoff JC, Bates DJ, Ross JS, Rothner AD, Cohen BH. Spinal MR findings in neurofibromatosis types 1 and 2. AJNR Am J Neuroradiol 1992; 13:1071–1077.PubMedGoogle Scholar
  82. 82.
    Bhargava R, Parham DM, Lasater OE, Chari RS, Chen G, Fletcher BD. MR imaging differentiation of benign and malignant peripheral nerve sheath tumors: use of the target sign. Pediatr Radiol 1997; 27:124–129.PubMedGoogle Scholar
  83. 83.
    Sobata E, Ohkuma H, Suzuki S. Cerebrovascular disorders associated with von Recklinghausen’s neurofibromatosis. Neurosurgery 1988; 22:544–549.PubMedGoogle Scholar
  84. 84.
    Nadig M, Munshi I, Short MP, Tonsgard JH, Sullivan C, Frim DM. A child with neurofibromatosis-1 and a lumbar epidural arteriovenous malformation. J Child Neurol 2000; 15:273–275.PubMedGoogle Scholar
  85. 85.
    Elster AD. Radiologic screening in the neurocutaneous syndromes: strategies and controversies. AJNR Am J Neuroradiol 1992; 13:1078–1082.PubMedGoogle Scholar
  86. 86.
    Bonawitz C, Castillo M, Chin CT, Mukherji SK, Barkovich AJ. Usefulness of contrast material in MR of patients with neurofibromatosis type 1. AJNR Am J Neuroradiol 1998; 19:541–546.PubMedGoogle Scholar
  87. 87.
    Listernick R, Charrow J, Gutmann DH. Intracranial gliomas in neurofibromatosis type 1. American Journal of Medical Genetics (Semin Med Genet) 1999; 89:38–44.Google Scholar
  88. 88.
    Lee TC, Sung ML, Chen JS. Tuberous sclerosis associated with neurofibromatosis: report of a case. J Formos Med Assoc 1994; 93:797–801.PubMedGoogle Scholar
  89. 89.
    Phillips CM, Rye B. Neurofibromatosis type 1 and tuberous sclerosis: a case of double phakomatosis. J Am Acad Dermatol 1994; 31:799–800.PubMedGoogle Scholar
  90. 90.
    Onal C, Bayindir C. Gliomatosis cerebri with neurofibromatosis: an autopsy-proven case. Childs Nerv Syst 1999; 15:219–221.PubMedGoogle Scholar
  91. 91.
    Artigas J, Carvos-Navarro J, Iglesias JR, Ebhardt G. Gliomatosis cerebri: clinical and histological findings. Clin Neuropathol 1985; 4:135–148.PubMedGoogle Scholar
  92. 92.
    Battistella PA, Perilongo G, Carollo C. Neurofibromatosis type 1 and type I Chiari malformation: an unusual association. Childs Nerv Syst 1996;12:336–338.PubMedGoogle Scholar
  93. 93.
    Dooley J, Vaughan D, Riding M, Camfield P. The association of Chiari type I malformation and neurofibromatosis type I. Clin Pediatr 1993; 32:189–190.Google Scholar
  94. 94.
    Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K, Haase VH, Ambrose CM, Munroe D, Bove C, Haines JL, Martuza RL, MacDonald ME, Seizinger BR, Short MP, Buckler AJ, Gusella JF. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 1993; 72:791–800.PubMedGoogle Scholar
  95. 95.
    Stokowski RP, Cox DR. Functional analysis of the neurofibromatosis type 2 protein by means of disease-causing point mutations. Am J Hum Genet 2000; 66:873–891.PubMedGoogle Scholar
  96. 96.
    Barbò R, Bonaldi G, Piazzalunga B. La neurofibromatosi tipo 2. Rivista di Neuroradiologia 2001; 14(Suppl 4):13–31.Google Scholar
  97. 97.
    Mautner VF, Lindenau M, Baser ME, Hazim W, Tatagiba M, Haase W, Samii M, Wais R, Pulst SM. The neuroimaging and clinical spectrum of neurofibromatosis 2. Neurosurgery 1996; 38:880–885.PubMedGoogle Scholar
  98. 98.
    Baser ME, Mautner VF, Ragge NK, Nechiporuk A, Riccardi VM, Klein J, Sainz J, Pulst SM. Presymptomatic diagnosis of neurofibromatosis 2 using linked genetic markers, neuroimaging, and ocular examinations. Neurology 1996; 47:1269–1277.PubMedGoogle Scholar
  99. 99.
    Patronas NJ, Courcoutsakis N, Bromley CM, Katzman GL, Mac-Collin M, Parry DM. Intramedullary and spinal canal tumors in patients with neurofibromatosis 2: MR imaging findings and correlation with genotype. Radiology 2001; 218:434–442.PubMedGoogle Scholar
  100. 100.
    Lekanne-Deprez RH, Bianchi AB, Groen NA, Seizinger BR, Hagameijer A, van Drunen E, Bootsma D, Koper JW, Avezaat GJ, Kley N. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Am J Hum Genet 1994;54:1022–1029.PubMedGoogle Scholar
  101. 101.
    Mautner VF, Tatagiba M, Guthoff R, Samii M, Pulst SM. Neurofibromatosis 2 in the pediatric age group. Neurosurgery 1993; 33:92–96.PubMedGoogle Scholar
  102. 102.
    Mautner VF, Tatagiba M, Lindenau M, Funsterer C, Pulst SM, Baser ME, Kluwe L, Zanella FE. Spinal tumors in patients with neurofibromatosis type 2: MR imaging study of frequency, multiplicity, and variety. AJR Am J Roentgenol 1995; 165:951–955.PubMedGoogle Scholar
  103. 103.
    Andreula CF, Recchia Luciani ANM. Neurofibromatosi tipo 2. In: Tortori-Donati P, Taccone A, Longo M (eds) Malformazioni cranio-encefaliche. Neuroradiologia. Torino: Minerva Medica, 1996:364–373.Google Scholar
  104. 104.
    Elster AD. Occult spinal tumors in neurofibromatosis: implications for screening. AJR Am J Roentgenol 1995; 165:956–957.PubMedGoogle Scholar
  105. 105.
    Cheadle JP, Reeve MP, Sampson JR, Kwiatkowski DJ. Molecular genetic advances in tuberous sclerosis. Hum Genet 2000; 107:97–114.PubMedGoogle Scholar
  106. 106.
    Dabora SL, Jozwiak S, Neal Franz D, Roberts PS, Nieto A, Chung J, Choy YS, Reeve MP, Thiele E, Egelhoff JC, Kasprzyk-Obara J, Domanska-Pakiela D, Kwiatkowski DJ. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet 2001; 68:64–80.PubMedGoogle Scholar
  107. 107.
    Osborne JP, Fryer A, Webb D. Epidemiology of tuberous sclerosis. Ann N Y Acad Sci 1991; 615:125–127.PubMedGoogle Scholar
  108. 108.
    Griffiths PD, Martland TR. Tuberous sclerosis complex: the role of neuroradiology. Neuropediatrics 1997; 28:244–252.PubMedGoogle Scholar
  109. 109.
    Roach ES, Smith M, Huttenlocher P, Bhat M, Alcorn D, Hawley L. Diagnostic criteria: tuberous sclerosis complex. Report of the Diagnostic Criteria Committee of the National Tuberous Sclerosis Association. J Child Neurol 1992; 7:221–224.PubMedGoogle Scholar
  110. 110.
    Roach ES, Gomez MR, Northrup H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol 1998; 13:624–628.PubMedGoogle Scholar
  111. 111.
    Huttenlocher PR, Wollmann RL. Cellular neuropathology of tuberous sclerosis. Ann N Y Acad Sci 1991; 615:140–148.PubMedGoogle Scholar
  112. 112.
    Braffman BH, Bilaniuk LT, Naidich TP, Altman NR, Post MJ, Quencer RM, Zimmerman RA, Brody BA. MR imaging of tuberous sclerosis: pathogenesis of this phakomatosis, use of gadopentetate dimeglumine, and literature review. Radiology 1992; 183:227–238.PubMedGoogle Scholar
  113. 113.
    Bender BL, Yunis EJ. The pathology of tuberous sclerosis. Pathol Annu 1982; 17:339–382.PubMedGoogle Scholar
  114. 114.
    Curatolo P. Neurological manifestations of tuberous sclerosis complex. Childs Nerv Syst 1996; 12:515–521.PubMedGoogle Scholar
  115. 115.
    Barkovich AJ, Kuzniecky RI, Jackson GD, Guerrini R, Dobyns WB. Classification system for malformations of cortical development. Update 2001. Neurology 2001;57:2168–2178.PubMedGoogle Scholar
  116. 116.
    Sarnat HB. Cytological nature of the cerebral lesions in tuberous slcerosis. In: Gomez MR (ed) Tuberous sclerosis, 2nd ed. New York: Raven Press; 1989:159–175.Google Scholar
  117. 117.
    Harding B, Copp AJ. Malformations. In: Greenfield’s neuropathology. Graham DI, Lantos PL (eds), 6th edn. London: Arnold, 1997:397–536.Google Scholar
  118. 118.
    Hart BL, Depper MH, Clericuzio CL. Neurocutaneous syndromes. In: Orrison WW, Jr (ed) Neuroimaging. Philadelphia: WB Saunders, 2000:1717–1759.Google Scholar
  119. 119.
    Shepherd CW, Houser OW, Gomez MR. MR findings in tuberous sclerosis complex and correlation with seizure development and mental impairment. AJNR Am J Neuroradiol 1995; 16:149–155.PubMedGoogle Scholar
  120. 120.
    Baron Y, Barkovich AJ. MR imaging of tuberous sclerosis in neonates and young infants. AJNR Am J Neuroradiol 1999; 20:907–916.PubMedGoogle Scholar
  121. 121.
    Hahn JS, Bejar R, Gladson CL. Neonatal subependymal giant cell astrocytoma associated with tuberous sclerosis: MRI, CT, and ultrasound correlation. Neurology 1991; 41:124–128.PubMedGoogle Scholar
  122. 122.
    Christophe C, Bartholome J, Blum D, Clerckx A, Desprechins B, De Wolf D, Gallez A, Viart P, Perlmutter N. Neonatal tuberous sclerosis. US, CT, and MR diagnosis of brain and cardiac lesions. Pediatr Radiol 1989; 19:446–448.PubMedGoogle Scholar
  123. 123.
    Wippold FJ, Baber WW, Gado M, Tobben PJ, Bartnicke BJ. Pre-and postcontrast MR studies in tuberous sclerosis. J Comput Assist Tomogr 1992; 16:69–72.PubMedGoogle Scholar
  124. 124.
    Nixon JR, Houser OW, Gomez MR, Okazaki H. Cerebral tuberous sclerosis: MR imaging. Radiology 1989; 170:869–873.PubMedGoogle Scholar
  125. 125.
    Marti-Bonmati L, Menor F, Dosda R. Tuberous sclerosis: differences between cerebral and cerebellar cortical tubers in a pediatric population. AJNR Am J Neuroradiol 2000; 21:557–560.PubMedGoogle Scholar
  126. 126.
    Wilms G, van Wijck E, Demaerel PH, Smet MH, Plets C, Brucher JM. Gyriform calcifications in tuberous sclerosis simulating the appearance of Sturge-Weber disease. AJNR Am J Neuroradiol 1992; 13:295–297.PubMedGoogle Scholar
  127. 127.
    Inoue Y, Nemoto Y, Murata R, Tashiro T, Shakudo M, Kohno K, Matsuoka O, Mochizuki K. CT and MR imaging of cerebral tuberous sclerosis. Brain Dev 1998; 20:209–221.PubMedGoogle Scholar
  128. 128.
    Kingsley DPE, Kendall BE, Fitz CR. Tuberous sclerosis: a clinicoradiological evaluation of 110 cases with particular reference to atypical presentation. Neuroradiology 1986; 28:38–46.PubMedGoogle Scholar
  129. 129.
    Geist RT, Gutmann DH. The tuberous sclerosis 2 gene is expressed at high levels in the cerebellum and developing spinal cord. Cell Growth Differentiation 1995; 6:1471–1483.Google Scholar
  130. 130.
    Arbelaez A, Castillo M. Magnetic resonance imaging of cerebellar lesions in patients with tuberous sclerosis. Int J Neuroradiol 1998; 4:412–416.Google Scholar
  131. 131.
    Asano E, Chugani DC, Muzik O, Shen C, Juhasz C, Janisse J, Ager J, Canady A, Shah JR, Shah AK, Watson C, Chugani HT. Multimodality imaging for improved detection of epileptogenic foci in tuberous sclerosis complex. Neurology 2000; 54:1976–1984.PubMedGoogle Scholar
  132. 132.
    Takanashi J, Sugita K, Fujii K, Niimi H. MR evaluation of tuberous sclerosis: increased sensitivity with fluid-attenuated inversion recovery and relation to severity of seizures and mental retardation. AJNR Am J Neuroradiol 1995; 16:1923–1928.PubMedGoogle Scholar
  133. 133.
    Tortori-Donati P, Fondelli MP, Rossi A, Andreussi L. Sclerosi tuberosa (M. di Bourneville). In: Tortori-Donati P, Taccone A, Longo M (eds). Malformazioni cranio-encefaliche. Neuroradiologia. Torino: Minerva Medica, 1996:375–390.Google Scholar
  134. 134.
    Martin N, Debussche C, DeBroucker T, Mompoint D, Marsault C, Nahum H. Gadolinium-DTPA enhanced MR imaging in tuberous sclerosis. Neuroradiology 1990; 31:492–497.PubMedGoogle Scholar
  135. 135.
    Van Tassel P, Cure JK, Holden KR. Cystlike white matter lesions in tuberous sclerosis. AJNR Am J Neuroradiol 1997; 18:1367–1373.PubMedGoogle Scholar
  136. 136.
    Girard N, Zimmerman RA, Schnur RE, Haselgrove J, Christensen K. Magnetization transfer in the investigation of patients with tuberous sclerosis. Neuroradiology 1997; 39:523–528.PubMedGoogle Scholar
  137. 137.
    Zulch KJ. Brain tumors, 5th edn. Berlin: Springer, 1986.Google Scholar
  138. 138.
    Coates TL, Hinshaw DB, Peckman N, Thompson JR, Hasso AN, Holshouser BA, Knierim DS. Pediatric choroid plexus neoplasms: MR, CT and pathologic correlation. Radiology 1989; 173:81–88.PubMedGoogle Scholar
  139. 139.
    Kleihues P, Burger PC, Scheithauer BW. Histological typing of tumors of the central nervous system, 2nd edn. Berlin: Springer, 1994.Google Scholar
  140. 140.
    Wolpert SM, Barnes PD. MRI in pediatric neuroradiology. St.Louis: Mosby, 1992.Google Scholar
  141. 141.
    Iwasaki Y, Yoshikawa H, Saski M, Sugai K, Suzuki H, Hirayama Y, Sakuragawa N, Arima M, Takashima S, Aoki N. Clinical and immunohistochemical studies of subependymal giant cell astrocytomas associated with tuberous sclerosis. Brain Dev 1990;12:478–481.PubMedGoogle Scholar
  142. 142.
    Morimoto K, Mogami H. Sequential CT study of subependymal giant cell astrocytoma associated with tuberous sclerosis. J Neurosurg 1986; 65:874–877.PubMedGoogle Scholar
  143. 143.
    Bell DG, King BF, Hattery RR, Charboneau JW, Hoffman AD, Houser OW. Imaging characteristics of tuberous sclerosis. AJR Am J Roentgenol 1991; 156:1081–1086.PubMedGoogle Scholar
  144. 144.
    McConachie NS, Worthington BS, Cornford EJ, Balsitis M, Kerslake RW, Jaspan T. Computed tomography and magnetic resonance in the diagnosis of intraventricular cerebral masses. Br J Radiol 1994; 67:223–243.PubMedGoogle Scholar
  145. 145.
    Torres OA, Roach ES, Delgado MR, Sparagana SP, Sheffield E, Swift D, Bruce D. Early diagnosis of subependymal giant cell astrocytoma in patients with tuberous sclerosis. J Child Neurol 1998;13:173–177.PubMedGoogle Scholar
  146. 146.
    Hilal SK, Solomon GE, Gold AP, Carter S. Primary cerebral arterial occlusive disease in children. II. Neurocutaneous syndromes. Radiology 1971; 99:87–94.PubMedGoogle Scholar
  147. 147.
    Gomez MR. Phenotypes of the tuberous sclerosis complex with a revision of diagnostic criteria. Ann N Y Acad Sci 1991; 615:1–7.PubMedGoogle Scholar
  148. 148.
    Gomez MR. Strokes in tuberous sclerosis: are rhabdomyomas a cause? Brain Dev 1989; 11:14–19.PubMedGoogle Scholar
  149. 149.
    Beltramello A, Puppini G, Bricolo A, Andreis IA, el-Dalati G, Longa L, Polidoro S, Zavarise G, Marradi P. Does the tuberous sclerosis complex include intracranial aneurysms? A case report with a review of the literature. Pediatr Radiol 1999; 29:206–211.PubMedGoogle Scholar
  150. 150.
    Roach ES, DiMario FJ, Kandt RS, Northrup H. Tuberous Sclerosis Consensus Conference: recommendations for diagnostic evaluation. National Tuberous Sclerosis Association. J Child Neurol 1999; 14:401–407.PubMedGoogle Scholar
  151. 151.
    DiMario FJ Jr, Cobb RJ, Ramsby GR, Leicher C. Familial band heterotopias simulating tuberous sclerosis. Neurology 1993; 43:1424–1426.PubMedGoogle Scholar
  152. 152.
    Bronen RA, Vives KP, Kim JH, Fulbright RK, Spencer SS, Spencer DD. Focal cortical dysplasia of Taylor, balloon cell subtype: MR differentiation from low-grade tumors. AJNR Am J Neuroradiol 1997; 18:1141–1151.PubMedGoogle Scholar
  153. 153.
    Palmini A, Andermann F, Olivier A, Tampieri D, Robitaille Y, Andermann E, Wright G. Focal neuronal migration disorders and intractable partial epilepsy: a study of 30 patients. Ann Neurol 1991; 30:741–749.PubMedGoogle Scholar
  154. 154.
    Palmini A, Andermann F, Olivier A, Tampieri D, Robitaille Y. Focal neuronal migration disorders and intractable partial epilepsy: results of surgical treatment. Ann Neurol 1991; 30:750–757.PubMedGoogle Scholar
  155. 155.
    Yagishita A, Arai N. Cortical tubers without other stigmata of tuberous sclerosis: imaging and pathological findings. Neuroradiology 1999; 41:428–432.PubMedGoogle Scholar
  156. 156.
    Taylor D, Falconer M, Bruton C, Corsellis J. Focal dysplasia of the cerebral cortex in epilepsy. J Neurol Neurosurg Psychiatry 1971; 34:369–387.PubMedGoogle Scholar
  157. 157.
    Honavar M, Meldrum B. Epilepsy. In: Graham DI, Lantos PL (eds) Greenfield’s Neuropathology, 6th edn. London: Arnold, 1997:936–938.Google Scholar
  158. 158.
    Menor F, Marti-BonmatÌ L, Mulas F, Poyatos C, Cortina H. Neuroimaging in tuberous sclerosis: a clinicoradiological evaluation in pediatric patients. Pediatr Radiol 1992; 183:227–238.Google Scholar
  159. 159.
    DiPaolo D, Zimmerman RA. Solitary cortical tuber. AJNR Am J Neuroradiol 1995; 16:1360–1364.PubMedGoogle Scholar
  160. 160.
    Jay V, Becker LE. Pathology of epilepsy. In: Davis RL, Robertson DM (eds). Textbook of Neuropathology, 3rd ed. Baltimore: Williams & Wilkins, 1991:394–397.Google Scholar
  161. 161.
    Yagishita A, Arai N, Maehara T, Shimizu N, Tokumaru AM, Oda M. Focal cortical dysplasia: appearance on MR images. Radiology 1997; 203:553–559.PubMedGoogle Scholar
  162. 162.
    Barkovich AJ, Chuang SH. Unilateral megalencephaly: correlation of MR imaging and pathologic characteristics. AJNR Am J Neuroradiol 1990;11:523–531.PubMedGoogle Scholar
  163. 163.
    Griffiths PD, Gardner SA, Smith M, Rittey C, Powell T. Hemimegalencephaly and focal megalencephaly in tuberous sclerosis complex. AJNR Am J Neuroradiol. 1998;19:1935–1938.PubMedGoogle Scholar
  164. 164.
    Eren S, Polat P, Erman Z. An unusual tuberous sclerosis case presenting with fibrillary astrocytoma. Pediatr Neurosurg 2002; 37:118–121.PubMedGoogle Scholar
  165. 165.
    Tortori-Donati P, Fondelli MP, Taccone A, Rossi A. Angiomatosi encefalo-trigeminale (Sindrome di Sturge-Weber). In: Tortori-Donati P, Taccone A, Longo M (eds) Malformazioni cranio-encefaliche. Neuroradiologia. Torino: Minerva Medica, 1996:391–398.Google Scholar
  166. 166.
    Gorman RJ, Snead OC. Sturge-Weber syndrome without port-wine nevus. Pediatrics 1977; 60:785.PubMedGoogle Scholar
  167. 167.
    Aydin A, Cakmakci H, Kovanlikaya A, Dirik E. Sturge-Weber syndrome without facial nevus. Pediatr Neurol 2000;22:400–402.PubMedGoogle Scholar
  168. 168.
    Martínez Bermejo A, Tendero A, López-Martín V, Arcas J, Royo A, Polanco I, Viao J, Pascual-Castroviejo I. Occipital leptomeningeal angiomatosis without facial angioma. Could it be considered a variant of Sturge-Weber syndrome? Rev Neurol 2000; 30:837–841.PubMedGoogle Scholar
  169. 169.
    Roach ES. Diagnosis and management of Neurocutaneous syndromes. Semin Neurol 1988;8:83–96.PubMedGoogle Scholar
  170. 170.
    Alexander GL. Sturge-Weber syndrome. In: Vinken PJ, Bruyn GW (eds). Handbook of clinical neurology: the phakomatoses. Amsterdam: North Holland, 1972:223–240.Google Scholar
  171. 171.
    Marti-Bonmati L, Menor F, Mulas F. The Sturge-Weber syndrome: correlation between the clinical status and radiological CT and MRI findings. Childs Nerv Syst 1993; 9:107–109.PubMedGoogle Scholar
  172. 172.
    Pascual-Castroviejo I, Diaz-Gonzalez C, Garcia-Melian RM, Gonzalez-Casado I, Munoz-Hiraldo E. Sturge-Weber syndrome: study of 40 patients. Pediatr Neurol 1993; 9:283–288.PubMedGoogle Scholar
  173. 173.
    Maria BL, Neufeld JA, Rosainz LC, Ben-David K, Drane WE, Quisling RG, Hamed LM. High prevalence of bihemispheric structural and functional defects in Sturge-Weber syndrome. J Child Neurol 1998; 13:595–605.PubMedGoogle Scholar
  174. 174.
    Bentson JR, Gabriel HW, Newton TH. Cerebral venous drainage pattern of the Sturge-Weber syndrome. Radiology 1971; 101:111–118.PubMedGoogle Scholar
  175. 175.
    Maria BL, Neufeld JA, Rosainz LC, Drane WE, Quisling RG, Ben-David K, Hamed LM. Central nervous system structure and function in Sturge-Weber syndrome: evidence of neurologic and radiologic progression. J Child Neurol 1998; 13:606–618.PubMedGoogle Scholar
  176. 176.
    Stimac GK, Soloman MA, Newton TH. CT and MR of angiomatous malformations of the choroid plexus in patients with Sturge-Weber disease. AJNR Am J Neuroradiol 1986; 7:623–627.PubMedGoogle Scholar
  177. 177.
    Griffiths PD, Blaser S, Boodram MB, Armstrong D, Harwood-Nash D. Choroid plexus size in young children with Sturge-Weber syndrome. AJNR Am J Neuroradiol 1996; 17:175–180.PubMedGoogle Scholar
  178. 178.
    Benedikt RA, Brown DC, Walker R, Ghaed VN, Mitchell M, Geyer CA. Sturge-Weber syndrome: cranial MR imaging with Gd-DTPA. AJNR Am J Neuroradiol 1993; 14:409–415.PubMedGoogle Scholar
  179. 179.
    Vogl TJ, Stemmler J, Bergman C, Pfluger T, Egger E, Lissner J. MR and MR angiography of Sturge-Weber syndrome. AJNR Am J Neuroradiol 1993; 14:417–425.PubMedGoogle Scholar
  180. 180.
    Fischbein NJ, Barkovich AJ, Wu Y, Berg BO. Sturge-Weber syndrome with no leptomeningeal enhancement on MRI. Neuroradiology 1998; 40:177–180.PubMedGoogle Scholar
  181. 181.
    Decker T, Jones K, Barnes P. Sturge-Weber syndrome with posterior fossa involvement. AJNR Am J Neuroradiol 1994; 15:389–392.PubMedGoogle Scholar
  182. 182.
    Yeakley JW, Woodside M, Fenstermacher MJ. Bilateral neonatal Sturge-Weber-Dimitri disease: CT and MR findings. AJNR Am J Neuroradiol 1992; 13:1179–1182.PubMedGoogle Scholar
  183. 183.
    Adamsbaum C, Pinton F, Rolland Y, Chiron C, Dulac O, Kalifa G. Accelerated myelination in early Sturge-Weber syndrome: MRI-SPECT correlations. Pediatr Radiol 1996; 26:759–762.PubMedGoogle Scholar
  184. 184.
    Griffiths PD. Sturge-Weber syndrome revisited: the role of neuroimaging. Neuropediatrics 1996; 27:284–294.PubMedGoogle Scholar
  185. 185.
    Laufer L, Cohen A. Sturge-Weber syndrome associated with a large left hemispheric arteriovenous malformation. Pediatr Radiol 1994; 24:272–273.PubMedGoogle Scholar
  186. 186.
    Griffiths PD, Boodram MB, Blaser S, Altomare F, Buncic JR, Levin AV, Jay V, Armstrong D, Harwood-Nash D. Abnormal ocular enhancement in Sturge-Weber syndrome: correlation of ocular MR and CT findings with clinical and intracranial imaging findings. AJNR Am J Neuroradiol 1996; 17:749–754.PubMedGoogle Scholar
  187. 187.
    Gobbi G, Sorrenti G, Santucci M, Rossi PG, Ambrosetto P, Micheluci R, Tassinari CA. Epilepsy with bilateral occipital calcifications: a benign onset with progressive severity. Neurology 1988; 38:913–920.PubMedGoogle Scholar
  188. 188.
    Gobbi G, Bouquet F, Greco L, Lambertini A, Tassinari CA, Ventura A, Zaniboni MG. Coeliac disease, epilepsy, and cerebral calcifications. The Italian Working Group on Coeliac Disease and Epilepsy. Lancet 1992; 340:439–443.PubMedGoogle Scholar
  189. 189.
    Bye AM, Andermann F, Robitaille Y, Oliver M, Bohane T, Andermann E. Cortical vascular abnormalities in the syndrome of celiac disease, epilepsy, bilateral occipital calcifications, and folate deficiency. Ann Neurol 1993; 34:399–403.PubMedGoogle Scholar
  190. 190.
    Longo M, Magaudda A, Blandino A, Oddone M. Sindrome delle calcificazioni occipitali bilaterali, epilessia e malattia celiaca. In: Tortori-Donati P, Taccone A, Longo M (eds). Malformazioni cranio-encefaliche. Neuroradiologia. Torino: Minerva Medica, 1996:405–408.Google Scholar
  191. 191.
    Piattella L, Zamponi N, Cardinali C, Porfiri L, Tavoni MA. Endocranial calcifications, infantile celiac disease, and epilepsy. Childs Nerv Syst 1993; 9:172–175.PubMedGoogle Scholar
  192. 192.
    Lea MA, Harbord M, Sage MR. Bilateral occipital calcification associated with celiac disease, folate deficiency and epilepsy. AJNR Am J Neuroradiol 1995; 16:1498–1500.PubMedGoogle Scholar
  193. 193.
    Oddone M, Veneselli E, Tomà P, Baglietto MG. Epilessia e calcificazioni cortico-sottocorticali bilaterali senza angiomatosi: sindrome di Sturge-Weber atipica? In: Rosa ML (ed). Neuroradiologia. Udine: Ed. del Centauro, 1991;479.Google Scholar
  194. 194.
    Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993; 260:1317–1320.PubMedGoogle Scholar
  195. 195.
    Filling-Katz MR, Choyke PL, Oldfield E, Charnas L, Patronas NJ, Glenn GM, Gorin MB, Morgan JK, Linehan WM, Seizinger BR. Central nervous system involvement in von Hippel-Lindau disease. Neurology 1991; 41:41–46.PubMedGoogle Scholar
  196. 196.
    Ho VB, Smirniotopoulos JG, Murphy FM, Rushin EJ. Radiologic-pathologic correlation: hemangioblastoma. AJNR Am J Neuroradiol 1992; 13:1343–1352.PubMedGoogle Scholar
  197. 197.
    Neumann HP, Eggert HR, Scheremet R, Schumacher M, Mohadjer M, Wakhloo AK, Volk B, Hettmannsperger U, Riegler P, Schollmeyer P. Central nervous system lesions in von Hippel-Lindau syndrome. J Neurol Neurosurg Psychiatry 1992; 55:898–901.PubMedGoogle Scholar
  198. 198.
    Lantos PL, VandenBerg SR, Kleihues P. Tumours of the nervous system. In: Graham DI, Lantos PL (eds) Greenfield’s Neuropathology, 6th edn. London: Arnold,1997:583–880.Google Scholar
  199. 199.
    Andreula CF, Recchia-Luciani ANM. Malatia di von Hippel-Lindau. In: Tortori-Donati P, Taccone A, Longo M (eds). Malformazioni cranio-encefaliche. Neuroradiologia. Torino: Minerva Medica, 1996:399–403.Google Scholar
  200. 200.
    Choyke PL, Glenn GM, Walther MM, Patronas NJ, Linehan WM, Zbar B. von Hippel-Lindau disease: genetic, clinical, and imaging features. Radiology 1995; 194:629–642.PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Paolo Tortori-Donati
    • 1
  • Andrea Rossi
    • 1
  • Roberta Biancheri
    • 1
  • Cosma F. Andreula
    • 2
  1. 1.Department of Pediatric NeuroradiologyG. Gaslini Children’s Research HospitalGenoaItaly
  2. 2.Diagnostic and Interventional Neuroradiology UnitAnthea HospitalBariItaly

Personalised recommendations